<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38610673</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Long COVID Clinical Severity Types Based on Symptoms and Functional Disability: A Longitudinal Evaluation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1908</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13071908</ELocationID><Abstract><AbstractText><b>Background</b>: Long COVID (LC) is a multisystem clinical syndrome with functional disability and compromised overall health. Information on LC clinical severity types is emerging in cross-sectional studies. This study explored the pattern and consistency of long COVID (LC) clinical severity types over time in a prospective sample. <b>Methods</b>: Participants with LC completed the condition-specific outcome measure C19-YRSm (Yorkshire Rehabilitation Scale modified version) at two assessment time points. A cluster analysis for clinical severity types was undertaken at both time points using the k-means partition method. <b>Results</b>: The study included cross-sectional data for 759 patients with a mean age of 46.8 years (SD = 12.7), 69.4% females, and a duration of symptoms of 360 days (IQR 217 to 703 days). The cluster analysis at first assessment revealed three distinct clinical severity type clusters: mild (<i>n</i> = 96), moderate (<i>n</i> = 422), and severe (<i>n</i> = 241). Longitudinal data on 356 patients revealed that the pattern of three clinical severity types remained consistent over time between the two assessments, with 51% of patients switching clinical severity types between the assessments. <b>Conclusions</b>: This study is the first of its kind to demonstrate that the pattern of three clinical severity types is consistent over time, with patients also switching between severity types, indicating the fluctuating nature of LC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0334-2968</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds LS11 0DL, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Demonstration Centre of Rehabilitation Medicine, Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Adam B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Leeds, Leeds LS2 9JT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leeds Institute for Data Analytics, University of Leeds, Leeds LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osborne</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3693-1056</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodwin</LastName><ForeName>Madeline</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Rom&#xe1;n Rocha</ForeName><Initials>RR</Initials><Identifier Source="ORCID">0000-0002-1913-9825</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ELAROS 24/7 Digital Company, Sheffield S1 2BJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baley</LastName><ForeName>Sareeta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Birmingham Community Healthcare NHS Trust, Birmingham B7 4BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hertfordshire Community NHS Trust, Welwyn AL6 9PW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Cassie</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0004-9449-0932</Identifier><AffiliationInfo><Affiliation>Imperial College Healthcare NHS Trust, London W2 1NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiff and Vale University Hospitals NHS Trust, Cardiff CF14 4XW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balasundaram</LastName><ForeName>Kumaran</ForeName><Initials>K</Initials><Identifier Source="ORCID">0009-0003-1119-4146</Identifier><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre-Respiratory &amp; Infection Theme, Glenfield Hospital, Leicester LE3 9QP, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenwood</LastName><ForeName>Darren C</ForeName><Initials>DC</Initials><Identifier Source="ORCID">0000-0001-7035-3096</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Leeds, Leeds LS2 9JT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leeds Institute for Data Analytics, University of Leeds, Leeds LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>LOCOMOTION Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>COV-LT2-0016</GrantID><Agency>National Institute for Health Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C19-YRS</Keyword><Keyword MajorTopicYN="N">LOCOMOTION</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">phenotypes</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword></KeywordList><CoiStatement>Rom&#xe1;n Rocha Lawrence is employed by University of Leeds and ELAROS 24/7 Ltd. who co-developed the digital PROM platform used to collect patient participant data and consent. The platform is offered to publicly funded organisations on a not-for-profit basis. The remaining authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38610673</ArticleId><ArticleId IdType="pmc">PMC11012375</ArticleId><ArticleId IdType="doi">10.3390/jcm13071908</ArticleId><ArticleId IdType="pii">jcm13071908</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Callard F., Perego E. How and why patients made Long COVID. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE . COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. NICE; Ra&#x2019;anana, Israel: 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., Condition WHOCCDWGoP-C A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>ONS  Prevalence of Ongoing Symptoms following Coronavirus (COVID-19) Infection in the UK: 2 February 2023.  [(accessed on 4 March 2023)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2february2023.</Citation></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Preston N., Parkin A., Makower S., Gee J., Ross D., Tarrant R., Davison J., Halpin S., O&#x2019;Connor R.J., et al. The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long Covid or Post-COVID-19 syndrome. J. Med. Virol. 2022;94:4253&#x2013;4264. doi: 10.1002/jmv.27878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27878</ArticleId><ArticleId IdType="pmc">PMC9348420</ArticleId><ArticleId IdType="pubmed">35603810</ArticleId></ArticleIdList></Reference><Reference><Citation>NHSEngland . National Guidance for Post-COVID Syndrome Assessment Clinics. NHSEngland; London, UK: 2021.</Citation></Reference><Reference><Citation>Ayuso Garcia B., Besteiro Balado Y., Perez Lopez A., Romay Lema E., Marchan-Lopez A., Rodriguez Alvarez A., Garcia Pais M.J., Corredoira Sanchez J., Rabunal Rey R. Assessment of Post-COVID Symptoms Using the C19-YRS Tool in a Cohort of Patients from the First Pandemic Wave in Northwestern Spain. Telemed. J. E-Health. 2023;29:278&#x2013;283. doi: 10.1089/tmj.2022.0085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/tmj.2022.0085</ArticleId><ArticleId IdType="pubmed">35727139</ArticleId></ArticleIdList></Reference><Reference><Citation>Gozdziewicz L., Tobis S., Chojnicki M., Wieczorowska-Tobis K., Neumann-Podczaska A. The Value of the COVID-19 Yorkshire Rehabilitation Scale in the Assessment of Post-COVID among Residents of Long-Term Care Facilities. Healthcare. 2024;12:333. doi: 10.3390/healthcare12030333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare12030333</ArticleId><ArticleId IdType="pmc">PMC10855238</ArticleId><ArticleId IdType="pubmed">38338218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kustura L., Bobek D., Poljicanin A., Pavelin S., Buljubasic Soda M., Soda J., Aksentijevic J., Duka Glavor K., Narancic Knez N., Viali V., et al. Psychometric properties and observational data for COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) for post-COVID-19 syndrome. QJM Int. J. Med. 2024;117:38&#x2013;47. doi: 10.1093/qjmed/hcad224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcad224</ArticleId><ArticleId IdType="pubmed">37788123</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamadoni N., Bakhtiari A., Nikbakht H.A. Psychometric properties of the COVID-19 Yorkshire Rehabilitation Scale: Post-COVID-19 syndrome in Iranian elderly population. BMC Infect. Dis. 2024;24:77. doi: 10.1186/s12879-024-08991-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-08991-0</ArticleId><ArticleId IdType="pmc">PMC10785474</ArticleId><ArticleId IdType="pubmed">38212717</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorst S.L., Seylanova N., Harman N., O&#x2019;Hara M., Terwee C.B., Williamson P.R., Needham D.M., Munblit D., Nicholson T., Group P.-C.S. A Core Outcome Measurement Set (COMS) for Research and Clinical Practice in Post COVID-19 Condition (Long COVID) in Adults: An International Delphi Consensus Study. Lancet Respir Med. p. 2023. in press .</Citation><ArticleIdList><ArticleId IdType="pubmed">37926103</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos T.D., Souza J.A., Cardoso D.M., Berni V.B., Pasqualoto A.S., de Albuquerque I.M. Predictors of Post-COVID-19 Functional Status Scale in Hospitalized Patients Recovering From SARS-CoV-2 Infection. Am. J. Phys. Med. Rehabil. 2024;103:143&#x2013;148. doi: 10.1097/PHM.0000000000002325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000002325</ArticleId><ArticleId IdType="pubmed">37594212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes S.E., Haroon S., Subramanian A., McMullan C., Aiyegbusi O.L., Turner G.M., Jackson L., Davies E.H., Frost C., McNamara G., et al. Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis. BMJ. 2022;377:e070230. doi: 10.1136/bmj-2022-070230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-070230</ArticleId><ArticleId IdType="pmc">PMC9043395</ArticleId><ArticleId IdType="pubmed">35477524</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M. Physical, cognitive and mental health impacts of COVID-19 after hospitalisation: A UK multicentre prospective cohort study. Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Parkin A., Makower S., Greenwood D.C. Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross-sectional evaluation from a community COVID rehabilitation service. J. Med. Virol. 2022;94:1419&#x2013;1427. doi: 10.1002/jmv.27456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27456</ArticleId><ArticleId IdType="pmc">PMC8661751</ArticleId><ArticleId IdType="pubmed">34783052</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Shi L., Jiang Z., Zeng N., Mei H., Lu Y., Yang J., Jin F., Ni S., Wu S., et al. The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China. Mol. Psychiatry. 2023;28:1793&#x2013;1801. doi: 10.1038/s41380-023-01951-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-01951-1</ArticleId><ArticleId IdType="pmc">PMC9869317</ArticleId><ArticleId IdType="pubmed">36690792</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A., Badier N., Zhang L., Elbeji A., Wilmes P., Oustric P., Benoy C., Ollert M., Fagherazzi G. Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study. Int. J. Environ. Res. Public Health. 2022;19:16018. doi: 10.3390/ijerph192316018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316018</ArticleId><ArticleId IdType="pmc">PMC9740149</ArticleId><ArticleId IdType="pubmed">36498091</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C., Martin-Guerrero J.D., Florencio L.L., Navarro-Pardo E., Rodriguez-Jimenez J., Torres-Macho J., Pellicer-Valero O.J. Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors. Infection. 2023;51:61&#x2013;69. doi: 10.1007/s15010-022-01822-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01822-x</ArticleId><ArticleId IdType="pmc">PMC9028890</ArticleId><ArticleId IdType="pubmed">35451721</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Greenhalgh T., Darbyshire J.L., Mir G., O&#x2019;Connor R.J., Dawes H., Greenwood D., O&#x2019;Connor D., Horton M., Petrou S. LOng COvid Multidisciplinary consortium Optimising Treatments and servIces acrOss the NHS (LOCOMOTION): Protocol for a mixed-methods study in the UK. BMJ Open. 2022;12:e063505. doi: 10.1136/bmjopen-2022-063505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-063505</ArticleId><ArticleId IdType="pmc">PMC9114312</ArticleId><ArticleId IdType="pubmed">35580970</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Rocha Lawrence R., O&#x2019;Brien P. Digital Patient Reported Outcome Measures Platform for Post-COVID-19 Condition and Other Long-Term Conditions: User-Centered Development and Technical Description. JMIR Hum. Factors. 2023;10:e48632. doi: 10.2196/48632.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/48632</ArticleId><ArticleId IdType="pmc">PMC10592725</ArticleId><ArticleId IdType="pubmed">37665334</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . World Health Organization International Classification of Functioning, Disability and Health. WHO; Geneva, Switzerland: 2001.</Citation></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl R., Leitl D., Schneeberger T., Jarosch I., Koczulla A.R. European Archives of Psychiatry and Clinical Neuroscience. Springer; Berlin/Heidelberg, Germany: 2023. Rehabilitative interventions in patients with persistent post COVID-19 symptoms-a review of recent advances and future perspectives.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-023-01631-9</ArticleId><ArticleId IdType="pubmed">37326700</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M.A., Duncan R., Hume E., Gough L., Roscoe C., Laddu D., Arena R., Asthon R.E.M., Dalton C. Progress in Cardiovascular Diseases. Elsevier; Amsterdam, The Netherlands: 2024. Developing effective strategies to optimize physical activity and cardiorespiratory fitness in the long Covid population&#x2014;The need for caution and objective assessment.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2024.03.003</ArticleId><ArticleId IdType="pubmed">38460898</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen R., Ashton R.E.M., Ferraro F.V., Skipper L., Bewick T., Leighton P., Phillips B.E., Faghy M.A. Forming a consensus opinion to inform long COVID support mechanisms and interventions: A modified Delphi approach. EClinicalMedicine. 2023;62:102145. doi: 10.1016/j.eclinm.2023.102145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102145</ArticleId><ArticleId IdType="pmc">PMC10432807</ArticleId><ArticleId IdType="pubmed">37599906</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Service England  Your Covid Recovery.  [(accessed on 21 March 2024)].  Available online:  https://www.nhs.uk/conditions/covid-19/long-term-effects-of-covid-19-long-covid/</Citation></Reference><Reference><Citation>WHO . In: Support for Rehabilitation: Self-Management after COVID-19-Related Illness. WHO, editor. WHO Regional Office for Europe; Copenhagen, Denmark: 2021.</Citation></Reference><Reference><Citation>Galland-Decker C., Marques-Vidal P., Vollenweider P. Prevalence and factors associated with fatigue in the Lausanne middle-aged population: A population-based, cross-sectional survey. BMJ Open. 2019;9:e027070. doi: 10.1136/bmjopen-2018-027070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-027070</ArticleId><ArticleId IdType="pmc">PMC6720133</ArticleId><ArticleId IdType="pubmed">31446404</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruscio A.M., Hallion L.S., Lim C.C.W., Aguilar-Gaxiola S., Al-Hamzawi A., Alonso J., Andrade L.H., Borges G., Bromet E.J., Bunting B., et al. Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder across the Globe. JAMA Psychiatry. 2017;74:465&#x2013;475. doi: 10.1001/jamapsychiatry.2017.0056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2017.0056</ArticleId><ArticleId IdType="pmc">PMC5594751</ArticleId><ArticleId IdType="pubmed">28297020</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien K.K., Brown D.A., McDuff K., St Clair-Sullivan N., Solomon P., Chan Carusone S., McCorkell L., Wei H., Goulding S., O&#x2019;Hara M., et al. Conceptualising the episodic nature of disability among adults living with Long COVID: A qualitative study. BMJ Glob. Health. 2023;8:e011276. doi: 10.1136/bmjgh-2022-011276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2022-011276</ArticleId><ArticleId IdType="pmc">PMC9979585</ArticleId><ArticleId IdType="pubmed">36863719</ArticleId></ArticleIdList></Reference><Reference><Citation>Stelson E.A., Dash D., McCorkell L., Wilson C., Assaf G., Re&#x2019;em Y., Wei H. Return-to-work with long COVID: An Episodic Disability and Total Worker Health(R) analysis. Soc. Sci. Med. 2023;338:116336. doi: 10.1016/j.socscimed.2023.116336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2023.116336</ArticleId><ArticleId IdType="pubmed">37918226</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>